ATM and Ataxia-telangiectasia: Using caffeine, a PI3 kinase-like inhibitor, KU 55933, an ATM-specific inhibitor [189], AT cells derived from patients with ataxia telangiectasia, or siRNAs to deplete ATM, results in reduced or blocked HCMV replication [94].